
Industry
Biotechnology
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
Loading...
Open
10.51
Mkt cap
7.6B
Volume
6M
High
10.80
P/E Ratio
-10.66
52-wk high
13.05
Low
10.43
Div yield
N/A
52-wk low
9.76
Portfolio Pulse from Benzinga Newsdesk
August 14, 2023 | 11:03 am
Portfolio Pulse from Chris Katje
July 28, 2023 | 8:33 pm
Portfolio Pulse from Happy Mohamed
July 27, 2023 | 12:11 pm
Portfolio Pulse from richadhand@benzinga.com
July 14, 2023 | 2:38 pm
Portfolio Pulse from Vandana Singh
July 14, 2023 | 12:55 pm
Portfolio Pulse from Benzinga Newsdesk
July 14, 2023 | 12:35 pm
Portfolio Pulse from Benzinga Newsdesk
July 14, 2023 | 8:44 am
Portfolio Pulse from Benzinga Newsdesk
July 06, 2023 | 6:43 pm
Portfolio Pulse from Benzinga Insights
June 29, 2023 | 2:45 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.